342
Views
65
CrossRef citations to date
0
Altmetric
Original

Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent

&
Pages 118-131 | Received 02 May 2007, Accepted 25 Jul 2007, Published online: 11 Jul 2009

References

  • Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 2000; 20: 2896–2903
  • Aberg MAI, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P, Rosengren LE, Olsson T, Gage FH, Eriksson PS. IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci 2003; 24: 23–40
  • Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 2006; 6: 53–80
  • Andersen PL, Webber CA, Kimura KA, Schreyer DJ. Cyclic AMP prevents an increase in GAP-43 but promotes neurite growth in cultured adult rat dorsal root ganglion neurons. Exp Neurol 2000a; 166: 153–165
  • Andersen PL, Webber CA, Whittemore SR, Schreyer DJ. Divergent regulation of GAP-43 expression and CNS neurite outgrowth by cyclic AMP. J Neurosci Res 2000b; 61: 626–635
  • Anderson MF, Aberg MA, Nilsson M, Eriksson PS. Insulin-like growth factor-1 and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 2002; 134: 115–122
  • Benowitz LI, Routtenberg A. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci 1997; 20: 84–91
  • Benowitz LI, Perrone-Bizzozero NI, Neve RL, Rodriguez W. GAP-43 as a marker for structural plasticity in the mature CNS. Prog Brain Res 1990; 86: 309–320
  • Bitar MS, Francis IM, Pilcher CW. Insulin-like growth factor 1-induced alterations in lumbospinal monoamine dynamics. Horm Metab Res 2000; 32: 207–215
  • Bondy CA, Lee WH. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann NY Acad Sci 1993; 692: 33–43
  • Bonthius DJ, Karacay B, Dai D, Pantazis NJ. FGF-2 NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and neuroprotective effects against alcohol toxicity in cerebellar granule cell cultures. Brain Res Dev Brain Res 2003; 140: 15–28
  • Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol 1998; 121: 19–26
  • Carro E, Torres-Aleman I. Serum insulin-like growth factor I in brain function. Keio J Med 2003; 55: 59–63
  • Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 2000; 20: 2926–2933
  • Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001; 21: 5678–5684
  • Chen MJ, Russo-Neustadt AA. Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Res Mol Brain Res 2005; 135: 181–193
  • Cheng CM, Mervis RF, Niu SL, Salem N, Jr., Witters LA, Tseng V, Reinhardt R, Bondy CA. Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res 2003; 73: 1–9
  • Chen B, Wang JF, Sun X, Young LT. Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol Psychiatry 2003; 53: 530–537
  • Chung YH, Joo KM, Nam RH, Lee WB, Lee KH, Cha CI. Region-specific alterations in insulin-like growth factor-I receptor in the central nervous system of nNOS knockout mice. Brain Res 2004; 1021: 132–139
  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231–241
  • De la Cruz CP, Revilla E, Rodriguez-Gomez JA, Vizuete ML, Cano J, Machado A. ( − )-Deprenyl treatment restores serum insulin-like growth factor-I (IGF-I) levels in aged rats to young rat level. Eur J Pharmacol 1997; 327: 215–220
  • Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 2001; 20: 252–259
  • Ding Q, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 2006; 140: 823–833
  • Dore S, Kar SQuirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci USA 1997; 94: 4772–4777
  • Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597–606
  • Engesser-Cesar C, Anderson AJ, Cotman CW. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience 2007; 144: 1033–1044
  • Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124: 71–79
  • Fournier AE, Beer J, Arregui CO, Essagian C, Aguayo AJ, McKerracher L. Brain-derived neurotrophic factor modulates GAP-43 but not T alpha1 expression in injured retinal ganglion cells of adult rats. J Neurosci Res 1997; 47: 561–572
  • Fressinaud C, Jean I, Dubas F. Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of unknown etiology. Acta Neuropathol (Berl) 2003; 105: 477–483
  • Fujimaki K, Morinobu S, Duman RS. Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacol 2000; 22: 42–51
  • Ghigo E, Arvat E, Gionotti L, Ramunni J, DiVito L, Maccagno B, Grottoli S, Camanni F. Human aging and the GH-IGF-1 axis. J Pediatr Endocrinol Metab 1996; 9(Suppl 3)271–278
  • Gispen WH, Nielander HB, De Graan PN, Oestreicher AB, Schrama LH, Schotman P. Role of the growth-associated protein B-50/GAP-43 in neuronal plasticity. Mol Neurobiol 1991; 5: 61–85
  • Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J Neurobiol 2004; 58: 60–69
  • Higo N, Oishi T, Yamashita A, Matsuda K, Hayashi M. Gene expression of growth-associated proteins, GAP-43 and SCG10, in the hippocampal formation of the macaque monkey: Nonradioactive in situ hybridization study. Hippocampus 1998; 8: 533–547
  • Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 2005; 1037: 204–208
  • Isaksson OG, Ohlsson C, Nilsson A, Isgaard J, Lindahl A. Regulation of cartilage growth by growth hormone and insulin-like growth factor I. Pediatr Nephrol 1991; 5: 451–453
  • Johnson-Farley NN, Travkina T, Cowen DS. Cumulative activation of akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J Pharmacol Exp Ther 2006; 316: 1062–1069
  • Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995; 267: 1658–1662
  • Kazanis I, Giannakopoulou M, Philippidis H, Stylianopoulou F. Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration. Exp Neurol 2004; 186: 221–234
  • Khawaja X, Xu J, Liang JJ, Barrett JE. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res 2004; 75: 451–460
  • Kim B, Leventhal PS, Saltiel AR, Feldman EL. Insulin-like growth factor-Imediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J Biol Chem 1997; 272: 21268–21273
  • Laifenfeld D, Klein E, Ben-Shachar D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: Relevance for major depression and antidepressant mechanisms. J Neurochem 2002; 83: 1054–1064
  • Lai M, Hibberd CJ, Gluckman PD, Seckl JR. Reduced expression of insulin-like growth factor 1 messenger RNA in the hippocampus of aged rats. Neurosci Lett 2000; 288: 66–70
  • Larsen MH, Rosenbrock H, Sams-Dodd F, Mikkelsen JD. Expression of brainderived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine. Eur J Pharmacol 2007; 555: 115–121
  • Laurino L, Wang XX, de la Houssaye BA, Sosa L, Dupraz S, Caceres A, Pfenninger KH, Quiroga S. PI3K activation by IGF-1 is essential for the regulation of membrane expansion at the nerve growth cone. J Cell Sci 2005; 118: 3653–3662
  • Lauterio TJ, Rieg TS, Ahmed I, Aravich PF. Fluoxetine induced insulin-like growth factor II (IGF-II) changes in hypothalami of normal, exercised and food restricted rats. Regul Pept 1993; 48: 21–28
  • Lavenius E, Parrow V, Nanberg E, Pahlman S. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors 1994; 10: 29–39
  • Lee FS, Rajagopal R, Chao MV. Distinctive features of Trk neurotrophin receptor transactivation by G-protein-coupled receptors. Cytokine Growth Factor Rev 2002; 13: 11–17
  • Lin X, Bulleit RF. Insulin-like growth factor I (IGF-I) is a critical trophic factor for developing cerebellar granule cells. Brain Res Dev Brain Res 1997; 99: 234–242
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
  • Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 1999; 11: 177–183
  • Malberg JE, Blendy JA. Antidepressant action: To the nucleus and beyond. Trends Pharmacol Sci 2005; 26: 631–638
  • Mattson MP, Maudsley S, Martin B. A neural signaling triumvirate that influences ageing and age-related disease: Insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 2004; 3: 445–464
  • McCusker RH, McCrea K, Zunich S, Dantzer R, Broussard SR, Johnson RW, Kelley KW. Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. J Neuroimmunol 2006; 179: 186–190
  • Meeusen R, De Meirleir K. Exercise and brain neurotransmission. Sports Med 1995; 20: 160–188
  • Molteni R, Ying Z, Gomez-Pinilla F. Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 2002; 16: 1107–1116
  • Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264–273
  • Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365–2372
  • Nitta A, Zheng WH, Quirion R. Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J Neurosci Res 2004; 76: 98–103
  • O'Kusky JR, Ye P, D'Ercole AJ. Insulin-like growth factor-1 promotes neurogenesis and synaptogensis in the hippocampal dentate gyrus during postnatal development. J Neurosci 2000; 20: 8435–8442
  • Pfenninger KH, Laurino L, Peretti D, Wang X, Rosso S, Morfini G, Caceres A, Quiroga S. Regulation of membrane expansion at the nerve growth cone. J Cell Sci 2003; 116: 1209–1217
  • Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch J E-B. Akt/protein kinase B up-regulates Bcl-2 expression through cAMPresponse element-binding protein. J Biol Chem 2000; 275: 10761–10766
  • Rekart JL, Meiri K, Routtenberg A. Hippocampal-dependent memory is impaired in heterozygous GAP-43 knockout mice. Hippocampus 2005; 15: 1–7
  • Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 2000; 275: 22583–22589
  • Russo-Neustadt AA, Chen MJ. Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des 2005; 11: 1495–1510
  • Russo-Neustadt A, Beard RC, Cotman CW. Exercise, antidepressant medications, and enhanced brain-derived neurotrophic factor expression. Neuropsychopharmacol 1999; 21: 679–682
  • Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000; 101: 305–312
  • Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activityantidepresssant treatment combination: Impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001; 120: 87–95
  • Schaeffer HJ, Sirotkin AV. Melatonin and serotonin regulate the release of insulin-like growth factor-I, oxytocin and progesterone by cultured human granulose cells. Exp Clin Endocrinol Diabetes 1997; 105: 109–112
  • Schauwecker PE, Cheng HW, Serquinia RM, Mori N, McNeill TH. Lesioninduced sprouting of commissural/associational axons and induction of GAP-43 mRNA in hilar and CA3 pyramidal neurons in the hippocampus are diminished in aged rats. J Neurosci 1995; 15: 2462–2470
  • Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE, Rosenzweig-Lipson S. Innovative approaches for the development of antidepressant drugs: Current and future strategies. NeuroRx 2005; 2: 590–611
  • Shah BH, Catt KJ. GPCR-mediated transactivation of RTKs in the CNS: Mechanisms and consequencces. Trends Neurosci 2004; 27: 48–53
  • Shaywitz AJ, Greenberg ME. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821–861
  • Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci 1989; 12: 127–156
  • Sortino MA, Canonico PL. Neuroprotective effect of insulin-like growth factor I in immortalized hypothalamic cells. Endocrinology 1996; 137: 1418–1422
  • Sumantran VN, Feldman EL. Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 1993; 132: 2017–2023
  • Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: A critical overview. Pharmacol Rev 2006; 58: 115–134
  • Tong L, Shen H, Perreau VM, Balazs R, Cotman CW. Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 2001; 8: 1046–1056
  • Torres-Aleman I. Serum growth factors and neuroprotective surveillance: Focus on IGF-1. Mol Neurobiol 2000; 21: 153–160
  • Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 2001; 21: 1628–1634
  • Werther GA, Russo V, Baker N, Butler G. The role of the insulin-like growth factor system in the developing brain. Horm Res 1998; 49(Suppl 1)37–40
  • Willaime-Morawek S, Arbez N, Mariani J, Brugg B. IGF-1 protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2?. Brain Res Mol Brain Res 2005; 142: 97–106
  • van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA 1999a; 96: 13427–13431
  • van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nature Neurosci 1999b; 2: 266–270

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.